Valuation Gedeon Richter LUXEMBOURG S.E.

Stocks

CHWGR

US3684672054

Pharmaceuticals

End-of-day quote LUXEMBOURG S.E. Other stock markets 06/07/2026			5-day change	1st Jan Change
39.40 ^USD	+0.51%		+1.55%	+30.46%

29/06	Gedeon Richter plc announces Resignation of Péter Cserháti as Member of the Board of Directors, with Effect from 1 July 2026	CI
16/06	AI in Hungary could unlock productivity gains of EUR15 billion, McKinsey says	RE

Company Valuation: Gedeon Richter

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	16,19,625	15,42,290	16,27,029	18,93,161	17,99,226	22,39,723	-	-
Change	-	-4.77%	5.49%	16.36%	-4.96%	24.48%	-	-
Enterprise Value (EV) ¹	15,59,769	13,95,557	15,46,536	17,82,343	15,88,618	19,25,133	18,18,333	16,99,718
Change	-	-10.53%	10.82%	15.25%	-10.87%	21.18%	-5.55%	-6.52%
P/E	11.6x	9.94x	10.2x	7.96x	7.76x	8.58x	7.87x	7.19x
PBR	1.78x	1.47x	1.44x	1.49x	1.31x	1.48x	1.34x	1.22x
PEG	-	0.9x	3.41x	0.2x	-2.82x	0.7x	0.88x	0.76x
Capitalization / Revenue	2.57x	1.92x	2.02x	2.21x	1.94x	2.35x	2.19x	2.04x
EV / Revenue	2.47x	1.74x	1.92x	2.08x	1.71x	2.02x	1.78x	1.55x
EV / EBITDA	8.86x	7.1x	6.43x	5.74x	4.5x	5.3x	4.66x	4.01x
EV / EBIT	11.5x	9.09x	8.15x	6.82x	5.42x	6.42x	5.57x	4.83x
EV / FCF	-460x	12.3x	17.9x	8.26x	7.56x	9.06x	7.86x	6.76x
FCF Yield	-0.22%	8.12%	5.6%	12.1%	13.2%	11%	12.7%	14.8%
Dividend per Share ²	225	390	-	-	-	620.6	664.4	733
Rate of return	2.58%	4.7%	-	-	-	5.05%	5.41%	5.97%
EPS ²	751	835	860	1,307	1,271	1,432	1,561	1,709
Distribution rate	30%	46.7%	-	-	-	43.3%	42.6%	42.9%
Net sales ¹	6,30,595	8,02,755	8,05,158	8,57,545	9,28,962	9,51,724	10,23,546	10,98,192
EBITDA ¹	1,76,123	1,96,480	2,40,625	3,10,678	3,53,314	3,63,366	3,89,794	4,24,113
EBIT ¹	1,35,832	1,53,555	1,89,817	2,61,157	2,92,851	2,99,996	3,26,732	3,51,898
Net income ¹	1,39,626	1,55,581	1,58,850	2,39,244	2,32,335	2,59,474	2,86,154	3,13,070
Net Debt ¹	-59,856	-1,46,733	-80,493	-1,10,818	-2,10,608	-3,14,590	-4,21,390	-5,40,005
Reference price ²	8,725.00	8,300.00	8,750.00	10,400.00	9,865.00	12,280.00	12,280.00	12,280.00
Nbr of stocks (in thousands)	1,85,630	1,85,818	1,85,946	1,82,035	1,82,385	1,82,388	-	-
Announcement Date	02/03/22	28/02/23	29/02/24	07/04/25	27/02/26	-	-	-

¹HUF in Million²HUF

Estimates

P/E, Detailed evolution

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	39.45x	7.49x	25.55x	0.79%	4.81TCr
OTSUKA HOLDINGS CO., LTD.	19.42x	2.2x	10.38x	1.25%	3.79TCr
CIPLA LIMITED	28.35x	3.51x	17.98x	0.85%	1.25TCr
ZYDUS LIFESCIENCES LIMITED	25.17x	4.36x	16.23x	0.71%	1.2TCr
KRKA, D. D.	19.59x	3.38x	12.29x	3.48%	902.96Cr
ONO PHARMACEUTICAL CO., LTD.	16.35x	2.1x	7.08x	3.2%	708.74Cr
GLENMARK PHARMACEUTICALS LIMITED	34.47x	3.93x	16.72x	0.23%	671.84Cr
AJANTA PHARMA LIMITED	40.23x	7.7x	28.57x	0.98%	441.68Cr
Average	27.88x	4.33x	16.85x	1.44%	1.72TCr
Weighted average by Cap.	28.98x	4.69x	17.72x	1.19%